Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences.

作者: Soraya Mezouar , Corinne Frère , Roxane Darbousset , Diane Mege , Lydie Crescence

DOI: 10.1016/J.THROMRES.2016.01.006

关键词: OncologyPathologyAngiogenesisThrombosisPlatelet activationPlateletCancer associated thrombosisMetastasisCancerHemostatic functionMedicineInternal medicine

摘要: The primary hemostatic function of platelets has been recognized for more than a century, but increasing experimental and clinical evidences suggest that are also important mediators cancer. Cancer indeed influences platelet physiology, activated participate in each step cancer development by promoting tumor growth, angiogenesis, metastasis, cancer-associated thrombosis. Based on both the results numerous models addressing involvement progression epidemiologic studies use anti-platelet drugs to prevent cancer, have proposed as potential target reduce short-term risk dissemination mortality. However, thrombosis bleeding due not enough evaluated models. Therefore, interesting contribution requires standardization preclinical

参考文章(165)
GM Ibele, NE Kay, GJ Johnson, HS Jacob, Human platelets exert cytotoxic effects on tumor cells Blood. ,vol. 65, pp. 1252- 1255 ,(1985) , 10.1182/BLOOD.V65.5.1252.1252
Noah S Scheinfeld, Barry Sloan, Pazopanib, a VEGF receptor tyrosine kinase inhibitor for cancer therapy. Current opinion in investigational drugs. ,vol. 9, pp. 1324- 1335 ,(2008)
MengJie Yan, Paul Jurasz, The role of platelets in the tumor microenvironment: From solid tumors to leukemia. Biochimica et Biophysica Acta. ,vol. 1863, pp. 392- 400 ,(2016) , 10.1016/J.BBAMCR.2015.07.008
RM Nelson, O Cecconi, WG Roberts, A Aruffo, RJ Linhardt, MP Bevilacqua, Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation Blood. ,vol. 82, pp. 3253- 3258 ,(1993) , 10.1182/BLOOD.V82.11.3253.3253
Christopher L. Hall, Cara W. Dubyk, Tracy A. Riesenberger, Daniel Shein, Evan T. Keller, Kenneth L. van Golen, Type I collagen receptor (α2β1) signaling promotes prostate cancer invasion through RhoC GTPase Neoplasia. ,vol. 10, pp. 797- 803 ,(2008) , 10.1593/NEO.08380
Shigeyoshi Itohara, Masatoshi Tanioka, Hiroshi Yoshida, Hirofumi Nishimoto, Takeshi Itoh, Takayuki Yoshioka, Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Research. ,vol. 58, pp. 1048- 1051 ,(1998)
Simon Gebremeskel, Terry LeVatte, Robert S. Liwski, Brent Johnston, Michael Bezuhly, The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer International Journal of Cancer. ,vol. 136, pp. 234- 240 ,(2015) , 10.1002/IJC.28947
Alok A. Khorana, Charles W. Francis, Eva Culakova, Gary H. Lyman, Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study Cancer. ,vol. 104, pp. 2822- 2829 ,(2005) , 10.1002/CNCR.21496
Tsunetada Yazaki, Hiromi Inage, Tatsuo Iizumi, Akio Koyama, Shori Kanoh, Kenkichi Koiso, Mitsuharu Narita, Shizuo Tojo, Studies on platelet function in patients with prostatic cancer. Preliminary report. Urology. ,vol. 30, pp. 60- 63 ,(1987) , 10.1016/0090-4295(87)90574-7
Kenjiro Tanoue, Goro Kosaki, Hisayo Kitagawa, Kazuo Yamamoto, Hiroh Yamazaki, Naomasa Yamamoto, Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells Cancer Research. ,vol. 49, pp. 537- 541 ,(1989)